TOSO interacts with SYK and enhances BCR pathway activation in chronic lymphocytic leukemia

BACKGROUND: TOSO, also named Fas inhibitory molecule 3 (FAIM3), has recently been identified as an immunoglobulin M (IgM) Fc receptor (FcμR). Previous studies have shown that TOSO is specifically over-expressed in chronic lymphocytic leukemia (CLL). However, the functions of TOSO in CLL remain unkno...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yan-Ru, Yu, Zhen, Xiong, Wen-Jie, Liu, Xu-Xiang, Liu, Hui-Min, Cui, Rui, Wang, Qi, Chen, Wen-Ming, Qiu, Lu-Gui, Yi, Shu-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478576/
https://www.ncbi.nlm.nih.gov/pubmed/32784334
http://dx.doi.org/10.1097/CM9.0000000000000999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478576/
https://www.ncbi.nlm.nih.gov/pubmed/32784334
http://dx.doi.org/10.1097/CM9.0000000000000999

Ejemplares similares